Feedback / Questions
resomelagon (AP1189) - SynAct Pharma
https://synactpharma.com/en/resomelagon-phase-2b-advance-study-update-190-patients-randomized-tracking-for-year-end-recruitment-completion/
Nov 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next